Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
Toyota (TM) Delivers Record Revenue but Operating Income Falls 8.8% in Q1

Toyota (TM) Delivers Record Revenue but Operating Income Falls 8.8% in Q1

Key Takeaways

  • Net profit surged 75.6% to 1.48 trillion yen ($9.4 billion) in Q1 FY2027, handily beating the consensus estimate of approximately 978 billion yen, though the jump was driven largely by currency gains and non-operating income rather than core automotive performance.
  • Operating income declined 8.8% to 1.06 trillion yen, marking the fifth consecutive quarter of year-over-year operating profit contraction. The operating margin narrowed to 7.9% from 9.5% a year earlier.
  • Revenue reached a quarterly record of 13.53 trillion yen ($84.5 billion), up 10.4% year-over-year and ahead of Bloomberg consensus of 13.06 trillion yen, aided by a significantly weaker yen that averaged 160 per dollar versus 145 a year ago.
  • Full-year guidance was raised across the board: operating income to 3.4 trillion yen (from 3 trillion), revenue to 54 trillion yen (from 51 trillion), and net profit to 3.25 trillion yen (from 3 trillion), though all three metrics remain below the prior fiscal year's results.
  • A 1 trillion yen ($6.3 billion) share buyback was announced alongside plans to cancel 200 million treasury shares, signaling management's focus on shareholder returns as the stock trades below book value.
  • Global vehicle sales slipped 0.7% to 2.395 million units, with steep declines in China (down 28%) and the Middle East (down roughly one-third) partially offset by modest growth in North America and Europe.

Why These Earnings Matter

TM's Q1 FY2027 results arrive at a pivotal moment for the world's largest automaker. The three months ended June 30, 2026, tested the company's ability to navigate converging headwinds: slumping demand in China as domestic electric vehicle brands gain share, supply chain disruptions tied to the Iran war that have driven up raw material costs and disrupted Middle East shipments, and the ongoing burden of 25% U.S. tariffs on vehicles built in Mexico and Canada. These pressures follow a fiscal 2026 in which Toyota posted record operating profit of 3.85 trillion yen — a high-water mark that makes year-over-year comparisons challenging. With five consecutive quarters of operating income declines now on the books, investors are scrutinizing whether the company's hybrid-focused product strategy and yen tailwinds can offset structural challenges in key markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Digging Into the Reported Numbers

TM's fiscal first quarter delivered a stark contrast between its top and bottom lines and the health of its core automotive operations. Consolidated sales revenue climbed 10.4% year-over-year to 13.53 trillion yen, exceeding the Bloomberg consensus estimate of 13.06 trillion yen and setting a new quarterly record. Net income attributable to Toyota Motor Corporation soared 75.6% to 1.48 trillion yen, far surpassing the Quick consensus poll estimate of 978.49 billion yen.

Beneath the surface, however, the earnings quality tells a more complex story. Operating income — the metric most closely watched by analysts as a gauge of core business performance — fell 8.8% to 1.06 trillion yen, coming in slightly below the market estimate of approximately 1.07 trillion yen. The operating margin contracted to 7.9% from 9.5% a year ago. Within the automotive segment specifically, operating profit declined 21%, and the automotive operating margin dropped from 8.26% to 5.99%.

The divergence between net profit and operating profit stems primarily from non-operating items. Other financial income surged from 153.7 billion yen to 850.5 billion yen, partly reflecting a one-time gain tied to the privatization of Toyota Industries. Foreign exchange gains swung from a loss of 212.3 billion yen a year ago to a gain of 112.3 billion yen. Toyota estimated that currency movements alone contributed 345 billion yen to operating profit during the quarter, as the yen averaged 160 per dollar compared to 145 in the same period last year.

On the volume front, consolidated vehicle sales edged down to 2.395 million units from 2.411 million a year earlier. China sales tumbled 28% as the market continued its rapid shift toward domestic EV brands, while Middle East volumes dropped by roughly one-third due to war-related logistics disruptions. North American sales inched up just 1%, lagging behind Detroit rivals that benefited from stronger pickup truck demand.

Management raised its full-year FY2027 forecasts: operating income is now projected at 3.40 trillion yen (up from 3.00 trillion), revenue at 54 trillion yen (up from 51 trillion), and net profit at 3.25 trillion yen (up from 3.00 trillion). The consolidated vehicle sales target was lifted to 9.70 million units from 9.60 million. Notably, these upgrades do not yet account for the impact of the July 28 Kumamoto earthquake, which forced production halts at four domestic plants.

Market Reaction and Investor Sentiment

Despite the headline earnings beat, upward guidance revision, and a sizable share buyback announcement, Toyota's stock closed down approximately 1.5% in Tokyo trading on August 4, with the U.S.-listed American Depositary Receipt (ADR) slipping 1.49% to $186.17. The market's tepid reception underscores a broader unease: investors recognized that the net profit surge was heavily reliant on currency tailwinds and non-operating gains rather than underlying operational strength. Analysts at Macquarie noted that the buyback, while substantial at 1 trillion yen, fell short of some expectations given Toyota's roughly 15 trillion yen net cash position and a price-to-book ratio below 1.0 — a level implying the market values the company below its accounting net worth. The stock has declined approximately 13% year-to-date, reflecting persistent concerns about tariff exposure, China market erosion, and margin compression in the core automotive business.

Forward Outlook and Key Factors to Monitor

As Toyota navigates the remainder of fiscal 2027, several interrelated dynamics will shape its trajectory. The upgraded full-year guidance provides a more optimistic framework, but delivering on these targets will require meaningful operational execution in the face of significant external pressures. From what I see, the currency tailwinds remain a double-edged sword worth watching closely.

The Iran war's impact on earnings is now estimated at 510 billion yen for the full year, down from the previous estimate of 670 billion yen. Toyota has successfully established alternative overland logistics routes to the Middle East that bypass the Strait of Hormuz, and expects only 25% of exports to the region to be affected from September onward, compared to an initial estimate of 50%. This operational adaptation offers a tangible buffer against further supply chain disruption.

Currency assumptions remain a critical variable. Toyota's forecasts are built on an exchange rate of 160 yen to the dollar, but coordinated U.S.-Japan intervention in late July pushed the yen to approximately 157. Should the yen continue to strengthen, the favorable translation effects that boosted first-quarter results could diminish in subsequent quarters. Every 1-yen move against the dollar carries a multi-billion-yen impact on operating profit. I’m watching this closely as it could reshape the rest of the year.

On the product front, Toyota's hybrid electric vehicle (HEV) strategy remains the linchpin of its competitive positioning. The company plans a 10% increase in hybrid sales to 5 million units this fiscal year and is expanding battery production capacity while transitioning from nickel-metal hydride to lithium-ion technology — a shift expected to reduce costs by several tens of thousands of yen per vehicle while improving performance. In North America, where hybrid demand is robust, the company must also contend with 25% tariffs on Mexican- and Canadian-built vehicles, a direct margin headwind with no near-term resolution in sight.

China presents arguably the most significant long-term challenge. Toyota's 28% quarterly sales decline in the world's largest auto market reflects a structural shift as domestic brands with advanced EV offerings capture market share. With Toyota's strategy still centered on hybrids rather than full battery-electric vehicles, its ability to stabilize and eventually reverse China losses will be closely watched. Meanwhile, the Kumamoto earthquake's production impact remains unquantified, adding an element of near-term uncertainty to an already complex operational landscape.

Enhancing My Analysis with Tickeron Tools

In my view, staying on top of complex earnings like these benefits from strong screening tools. I frequently use Tickeron’s AI Screener to filter opportunities and compare performance across sectors quickly. It helps surface patterns and signals that complement traditional analysis, making it easier to focus on what matters most for long-term positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TM

TM in upward trend: price rose above 50-day moving average on July 27, 2026

TM moved above its 50-day moving average on July 27, 2026 date and that indicates a change from a downward trend to an upward trend. In of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 21, 2026. You may want to consider a long position or call options on TM as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TM just turned positive on June 29, 2026. Looking at past instances where TM's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for TM crossed bullishly above the 50-day moving average on July 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TM advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 192 cases where TM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TM moved out of overbought territory on July 31, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where TM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TM broke above its upper Bollinger Band on July 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.947) is normal, around the industry mean (9.582). P/E Ratio (8.487) is within average values for comparable stocks, (578.639). Projected Growth (PEG Ratio) (1.556) is also within normal values, averaging (2.788). Dividend Yield (0.032) settles around the average of (0.037) among similar stocks. P/S Ratio (0.737) is also within normal values, averaging (11.830).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 63.99B. The market cap for tickers in the group ranges from 3.72K to 1.29T. TSLA holds the highest valuation in this group at 1.29T. The lowest valued company is ZAPPF at 3.72K.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was 0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -17%. SEV experienced the highest price growth at 19%, while LVWR experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -29% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 57
Price Growth Rating: 60
SMR Rating: 93
Profit Risk Rating: 92
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
TM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of motor vehicles and parts

Industry MotorVehicles

Profile
Details
Industry
Motor Vehicles
Address
1 Toyota-cho
Phone
+81 565282121
Employees
375235
Web
https://www.global.toyota
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.